About gMendel
gMendel is a medical technology company focused on transforming genetic diagnostics through AI-powered screening solutions for prenatal and newborn care. The company develops scalable tools for early detection of genetic conditions, aiming to make screening more accessible, accurate, and cost-effective.
Its platform is designed to support healthcare systems in improving early diagnosis and patient outcomes while reducing the overall cost burden of genetic testing at population scale, with a focus on expansion across Latin America, the Middle East, and Africa.
News and update
Why We Invested in gMendel to Scale Genetic Screening Across Latin America, the Middle East, and Africa. For more information
